Stemedica Cell Technologies, Inc., a US company with investment from JZT, reported remarkable benefits in a study using MSCs to treat 8 COVID-19 patients.
Stemedica Cell Technologies, Inc., a US company with investment from JZT, reported remarkable benefits in a study using MSCs to treat 8 COVID-19 patients.
Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Business License